← Leaderboards
George Q Daley
Whitehead Institute For Biomedical Res
$28,756,218
Attributed
$68,282,196
Total exposure
17
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$68,282,196 · 17
By mechanism
U01$21,246,194 · 3
RC2$11,604,216 · 2
R01$11,113,936 · 5
R24$10,696,987 · 1
DP1$4,159,595 · 1
UC4$4,109,951 · 1
Top collaborators
- Leonard I Zon28 shared
- James J Collins16 shared
- Trista E. North13 shared
- Jeffrey M Lipton7 shared
- Stuart H Orkin7 shared
- Akiko Shimamura7 shared
- Adrianna Vlachos7 shared
- Michael Allen Brehm6 shared
Most similar at Whitehead Institute For Biomedical Res
Same institution · by research overlap
- Lily Junshen Huang$7,679,685
- Wei Tong$21,627,247
- Peng Ji$11,066,372
- Rudolf Jaenisch$45,589,957
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VitroHematopoietic Stem CellsHematopoieticStem CellsEmbryoResearch PersonnelGeneticZebrafishPluripotent Stem CellsInsightBloodPathway InteractionsEmbryonic Stem CellInduced Pluripotent Stem CellGene ExpressionStemGenesHematopoiesisTissuesDerivation ProcedureCollaborationsImmuneCell Line
Grant awards (79)
Models to study the synergy between autoimmunity and metabolism in T1D$1,208,620
UG3 · FY2025 · DK
Molecular Circuits in the Hematopoietic Stem Cell Niche$1,516,828
RC2 · FY2024 · DK · contact PI
Molecular Circuits in the Hematopoietic Stem Cell Niche$1,604,652
RC2 · FY2023 · DK · contact PI
Molecular Circuits in the Hematopoietic Stem Cell Niche$1,635,341
RC2 · FY2022 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,206,728
U01 · FY2022 · HL · contact PI
Humanized Mouse Avatars for T1D$1,005,973
U01 · FY2022 · DK
Molecular Circuits in the Hematopoietic Stem Cell Niche$1,665,686
RC2 · FY2021 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,223,081
U01 · FY2021 · HL · contact PI
Humanized Mouse Avatars for T1D$1,008,786
U01 · FY2021 · DK
Molecular Circuits in the Hematopoietic Stem Cell Niche$1,749,532
RC2 · FY2020 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,235,586
U01 · FY2020 · HL · contact PI
Humanized Mouse Avatars for T1D$1,011,466
U01 · FY2020 · DK
Stem cells for therapeutics discovery in genetic blood disorders$1,251,085
U01 · FY2019 · HL · contact PI
Humanized Mouse Avatars for T1D$1,064,644
U01 · FY2019 · DK
Customized stem cells for clinical application in blood disorders$1,329,594
R24 · FY2018 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,264,005
U01 · FY2018 · HL · contact PI
Customized stem cells for clinical application in blood disorders$1,350,804
R24 · FY2017 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,030,943
U01 · FY2017 · HL · contact PI
LIN28/let-7 MECHANISMS IN REPROGRAMMING AND METABOLISM$457,142
R01 · FY2017 · GM · contact PI
Customized stem cells for clinical application in blood disorders$1,369,700
R24 · FY2016 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,044,680
U01 · FY2016 · HL · contact PI
LIN28/let-7 MECHANISMS IN REPROGRAMMING AND METABOLISM$440,502
R01 · FY2016 · GM · contact PI
Understanding the role of the lin28 paralogs and branching morphogenesis$84,302
R01 · FY2016 · GM · contact PI
Customized stem cells for clinical application in blood disorders$1,391,696
R24 · FY2015 · DK · contact PI
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,272,570
U01 · FY2015 · HL · contact PI
LIN28/let-7 MECHANISMS IN REPROGRAMMING AND METABOLISM$452,969
R01 · FY2015 · GM · contact PI
Humanized Mouse Avatars for T1D$4,109,951
UC4 · FY2014 · DK
Customized stem cells for clinical application in blood disorders$1,449,467
R24 · FY2014 · DK · contact PI
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,266,111
U01 · FY2014 · HL · contact PI
LIN28/let-7 MECHANISMS IN REPROGRAMMING AND METABOLISM$460,241
R01 · FY2014 · GM · contact PI
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,229,936
U01 · FY2013 · HL · contact PI
Customized stem cells for clinical application in blood disorders$1,193,861
R24 · FY2013 · DK · contact PI
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,291,950
U01 · FY2012 · HL · contact PI
Customized stem cells for clinical application in blood disorders$1,267,717
R24 · FY2012 · DK · contact PI
Customized stem cells for clinical application in blood disorders$7,830
R24 · FY2012 · DK · contact PI
Customized stem cells for clinical application in blood disorders$1,336,318
R24 · FY2011 · DK · contact PI
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,291,950
U01 · FY2011 · HL · contact PI
Novel therapies for Fanconi anemia$3,876,697
RC4 · FY2010 · DK
Comparative phenotypic, functional, and molecular analysis of ESC and iPSC$1,683,978
RC2 · FY2010 · HL · contact PI
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,264,200
U01 · FY2010 · HL · contact PI
Second International Conference on Stem Cell Engineering$5,000
R13 · FY2010 · HL · contact PI
Comparative phenotypic, functional, and molecular analysis of ESC and iPSC$1,748,199
RC2 · FY2009 · HL · contact PI
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,282,500
U01 · FY2009 · HL · contact PI
Murine Models for Regenerative Medicine$677,464
R01 · FY2009 · DK · contact PI
Hematopoietic Stem Cells from Pluripotent Embryonic Stem Cells$321,928
R01 · FY2009 · DK · contact PI
Murine Models for Regenerative Medicine$95,830
R01 · FY2009 · DK · contact PI
NIH Director's Pioneer Award$825,143
DP1 · FY2008 · OD · contact PI
Murine Models for Regenerative Medicine$663,883
R01 · FY2008 · DK · contact PI
Hematopoietic Stem Cells from Pluripotent Embryonic Stem Cells$321,928
R01 · FY2008 · DK · contact PI
NIH Director's Pioneer Award$825,143
DP1 · FY2007 · OD · contact PI
Murine Models for Regenerative Medicine$663,947
R01 · FY2007 · DK · contact PI
Hematopoietic Stem Cells from Pluripotent Embryonic Stem Cells$328,499
R01 · FY2007 · DK · contact PI
NIH Director's Pioneer Award$825,143
DP1 · FY2006 · OD · contact PI
Murine Models for Regenerative Medicine$670,246
R01 · FY2006 · DK · contact PI
Hematopoietic Stem Cells from Pluripotent Embryonic Stem Cells$338,309
R01 · FY2006 · DK · contact PI
NIH Director's Pioneer Award$844,166
DP1 · FY2005 · OD
Murine Models for Regenerative Medicine$725,074
R01 · FY2005 · DK
Hematopoietic Stem Cells from Pluripotent Embryonic Stem Cells$346,109
R01 · FY2005 · DK
Modeling Developmental Hematopoiesis with Embryonic Stem$243,000
R01 · FY2005 · HL
Therapeutic Mechanisms in Chronic Myelogenous Leukemia$232,321
R01 · FY2005 · CA
NIH Director's Pioneer Award (RMI)$840,000
DP1 · FY2004 · OD
Hematopoietic stem cells from totipotent stem cell types$364,500
R01 · FY2004 · DK
Therapeutic Mechanisms in Chronic Myelogenous Leukemia$253,572
R01 · FY2004 · CA
Modeling Developmental Hematopoiesis with Embryonic Stem$243,000
R01 · FY2004 · HL
Hematopoietic stem cells from totipotent stem cell types$266,944
R01 · FY2003 · DK
Therapeutic Mechanisms in Chronic Myelogenous Leukemia$260,576
R01 · FY2003 · CA
Modeling Developmental Hematopoiesis with Embryonic Stem$164,169
R01 · FY2003 · HL
Hematopoietic stem cells from totipotent stem cell types$160,556
R01 · FY2003 · DK
Hematopoietic stem cells from totipotent stem cell types$117,375
R01 · FY2003 · DK
Therapeutic Mechanisms in Chronic Myelogenous Leukemia$110,503
R01 · FY2003 · CA
Modeling Developmental Hematopoiesis with Embryonic Stem$85,690
R01 · FY2003 · HL
Hematopoietic stem cells from totipotent stem cell types$348,750
R01 · FY2002 · DK
Therapeutic Mechanisms in Chronic Myelogenous Leukemia$321,625
R01 · FY2002 · CA
Modeling Developmental Hematopoiesis with Embryonic Stem$234,750
R01 · FY2002 · HL
MOLECULAR PATHWAYS IN MYELOPROLIFERATIVE DISEASE$87,000
R29 · FY2002 · CA
Hematopoietic stem cells from totipotent stem cell types$348,750
R01 · FY2001 · DK
Therapeutic Mechanisms in Chronic Myelogenous Leukemia$309,482
R01 · FY2001 · CA
MOLECULAR PATHWAYS IN MYELOPROLIFERATIVE DISEASE$87,000
R29 · FY2001 · CA
MOLECULAR PATHWAYS IN MYELOPROLIFERATIVE DISEASE$87,000
R29 · FY2000 · CA